Tocilizumab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Tocilizumab (Actemra®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Tocilizumab. Another POD-labelled specific monoclonal antibody is used as conjugate.
Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Assay Format: Double specific mAb-based
Reference: IG-AB108
Barcode: 8682754930233
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AB108 694.46 KB
Material Safety Data Sheet (MSDS) IG-AB108 268.24 KB
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 130 |
| Sample | Serum or Plasma |
| Package Size | 96 |
| Standard Range (ng/mL, 10x) | 0-2000 |
| Detection Limit (ng/mL) | 5 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
